The International Diabetes Federation reported that, at present, there are 415 million subjects worldwide with diabetes mellitus (DM) aged between 20 and 79 years, with a global prevalence of 8.8%, which by 2030 will increase to >360 million.
MSC's (topical) in the Tx of Diabetic Foot Ulcer Dec 2017Three-week topical treatment with placenta – derived mesenchymal stem cells hydrogel in a patient with diabetic foot ulcer
By nsc116|2018-07-16T12:59:53+00:00July 16th, 2018|Diabetes, Mesenchymal Stem Cells, Skin Diseases, Stem Cells|Comments Off on Three-week topical treatment with placenta – derived mesenchymal stem cells hydrogel in a patient with diabetic foot ulcer
About the Author: nsc116
